Globus Medical Inc (NYSE:GMED)

$ 87.07 0.52 (0.6%) Market Cap: 11.86 Bil Enterprise Value: 11.70 Bil PE Ratio: 129.96 PB Ratio: 2.91 GF Score: 98/100

Q3 2024 Globus Medical Inc Earnings Call Transcript
Nov 05, 2024

$75.58 (+1.15%)

Earnings
Q2 2024 Globus Medical Inc Earnings Call Transcript
Aug 06, 2024

$69.05 (+1.84%)

Earnings
Q1 2024 Globus Medical Inc Earnings Call Transcript
May 07, 2024

$51.36 (+2.17%)

Earnings
Q4 2023 Globus Medical Inc Earnings Call Transcript
Feb 20, 2024

$54.16 (+0.63%)

Earnings
Q3 2023 Globus Medical Inc Earnings Call Transcript
Nov 07, 2023

$46.19 (-0.69%)

Earnings
Q2 2023 Globus Medical Inc Earnings Call Transcript
Aug 03, 2023

$57.79 (-3.18%)

Earnings
Q1 2023 Globus Medical Inc Earnings Call Transcript
May 04, 2023

$56.59 (-0.39%)

Earnings
Q4 2022 Globus Medical Inc Earnings Call Transcript
Feb 21, 2023

$59.13 (-1.74%)

Earnings
Globus Medical Inc and NuVasive Inc to Create Innovative Global Musculoskeletal Company Focused on Patient Care Call Transcript
Feb 09, 2023
Q3 2022 Globus Medical Inc Earnings Call Transcript
Nov 08, 2022

$64.29 (+0.05%)

Earnings
Q2 2022 Globus Medical Inc Earnings Call Transcript
Aug 04, 2022

$58.85 (-1.42%)

Earnings
Q1 2022 Globus Medical Inc Earnings Call Transcript
May 10, 2022

$61.22 (+1.24%)

Earnings
Globus Medical Inc to Discuss its CEO Transition Conference Call Transcript
Apr 21, 2022
Q4 2021 Globus Medical Inc Earnings Call Transcript
Feb 17, 2022

$66.34 (-2.97%)

Earnings
Q3 2021 Globus Medical Inc Earnings Call Transcript
Nov 04, 2021

$77.35 (-1.12%)

Earnings
Q2 2021 Globus Medical Inc Earnings Call Transcript
Aug 04, 2021

$80.63 (-2.42%)

Earnings
Q1 2021 Globus Medical Inc Earnings Call Transcript
May 04, 2021

$69.64 (-2.14%)

Earnings
Q4 2020 Globus Medical Inc Earnings Call Transcript
Feb 17, 2021

$66.72 (-0.95%)

Earnings
Q3 2020 Globus Medical Inc Earnings Call Transcript
Oct 28, 2020

$49.62 (-3.20%)

Earnings
Q2 2020 Globus Medical Inc Earnings Call Transcript
Aug 05, 2020

$50.66 (+3.83%)

Earnings
Q1 2020 Globus Medical Inc Earnings Call Transcript
May 07, 2020

$47.8 (+4.32%)

Earnings
Q4 2019 Globus Medical Inc Earnings Call Transcript
Feb 20, 2020

$56.45 (-0.19%)

Earnings
Q3 2019 Globus Medical Inc Earnings Call Transcript
Nov 06, 2019

$53.06 (+0.38%)

Earnings
Q2 2019 Globus Medical Inc Earnings Call Transcript
Aug 01, 2019

$46.39 (+1.78%)

Earnings
Q1 2019 Globus Medical Inc Earnings Call Transcript
May 02, 2019

$45.96 (+4.12%)

Earnings
Q4 2018 Globus Medical Inc Earnings Call Transcript
Feb 21, 2019

$47.69 (+0.19%)

Earnings

Q4 2023 Globus Medical Inc Earnings Call Transcript

Feb 20, 2024 / 09:30PM GMT

Release Date Price: $54.16 (+0.63%)

Transcript 10-K8-K

Operator

Okay, and thank you for standing by. Welcome to the Globus Medical's Fourth Quarter and Full Year 2023 Earnings Call.

(Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Brian Kearns, Senior Vice President of Investor -- of Business Development and Investor Relations. Please go ahead.

Brian J. Kearns

Globus Medical, Inc. - SVP of Business Development & IR

Thank you, Victor, and thank you, everyone, for being with us today.

Joining today's call from Globus Medical will be Dan Scavilla, President and CEO; and Keith Pfeil, Chief Operating and Chief Financial Officer. This review is being made available via webcast, accessible through the Investor Relations section of the Globus Medical website at www.globusmedical.com. Before we begin, let me remind you that some of the statements made during this review are or may be considered forward-looking statements. Our Form

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.